Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis.

Birnbaum, Michael D; Zhao, Ning; Moorthy, Balaji T; Patel, Devang M; Kryvenko, Oleksandr N; Heidman, Laine; Kumar, Akhilesh; Morgan, William M; Ban, Yuguang; Reis, Isildinha M; Chen, Xi; Gonzalgo, Mark L; Jorda, Merce; Burnstein, Kerry L; Zhang, Fangliang.
Oncogene; 2018 Sep 03.
Artigo em Inglês | MEDLINE | ID: mdl-30177837

Não foram localizados documentos relacionados